161 related articles for article (PubMed ID: 11249043)
1. Idiosyncratic reaction after oxaliplatin infusion.
Santini D; Tonini G; Salerno A; Vincenzi B; Patti G; Battistoni F; Dicuonzo G; Labianca R
Ann Oncol; 2001 Jan; 12(1):132-3. PubMed ID: 11249043
[No Abstract] [Full Text] [Related]
2. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
Schüll B; Kornek GV; Scheithauer W
Ann Oncol; 2001 Nov; 12(11):1653-4. PubMed ID: 11822769
[No Abstract] [Full Text] [Related]
3. [Successful management using laparoscopic splenectomy for splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced rectal cancer].
Koike N; Ohshima Y; Takeuchi T; Arita S; Shinozaki E
Gan To Kagaku Ryoho; 2013 Jun; 40(6):815-7. PubMed ID: 23863666
[TBL] [Abstract][Full Text] [Related]
4. [Standard chemotherapy for colonic neoplasms].
Hyodo I
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
[No Abstract] [Full Text] [Related]
5. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
6. Recurrent priapism related to oxaliplatin infusion.
Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
[No Abstract] [Full Text] [Related]
7. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
Sánchez Cendra C; Juez Martel I; Gutierrez Abad D
Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654
[No Abstract] [Full Text] [Related]
8. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer.
Gerard B; Bleiberg H; Van Daele D; Gil T; Hendlisz A; Di Leo A; Fernez B; Brienza S
Anticancer Drugs; 1998 Apr; 9(4):301-5. PubMed ID: 9635919
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
Koike J; Funahashi K; Yoshimatsu K; Yokomizo H; Kan H; Yamada T; Ishida H; Ishibashi K; Saida Y; Enomoto T; Katsumata K; Hisada M; Hasegawa H; Koda K; Ochiai T; Sakamoto K; Shiokawa H; Ogawa S; Itabashi M; Kameoka S
Cancer Chemother Pharmacol; 2017 Mar; 79(3):519-525. PubMed ID: 28150022
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
de Gramont A; Vignoud J; Tournigand C; Louvet C; André T; Varette C; Raymond E; Moreau S; Le Bail N; Krulik M
Eur J Cancer; 1997 Feb; 33(2):214-9. PubMed ID: 9135491
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.
Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B
Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye H; Bruserud Y; Dahl O
Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
[No Abstract] [Full Text] [Related]
15. High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
Maindrault-Goebel F; de Gramont A; Louvet C; André T; Carola E; Mabro M; Artru P; Gilles V; Lotz JP; Izrael V; Krulik M;
Eur J Cancer; 2001 May; 37(8):1000-5. PubMed ID: 11334725
[TBL] [Abstract][Full Text] [Related]
16. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.
Niu J; Mims MP
J Clin Oncol; 2012 Nov; 30(31):e312-4. PubMed ID: 22987080
[No Abstract] [Full Text] [Related]
18. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
19. Anaphylactic reaction to oxaliplatin: a case report.
Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
[No Abstract] [Full Text] [Related]
20. Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.
Stickel F; Jüngert B; Brueckl V; Schirner I; Brueckl WM; Männlein G; Hegewald J; Mühldorfer S; Bittorf B; Hohenberger W; Hahn EG; Wein A
Anticancer Drugs; 2003 Oct; 14(9):745-9. PubMed ID: 14551509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
